skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8102

Biologics: Targets and Therapy

(1,101,178) Views

Editor in Chief Dr Doris Mangiaracina Benbrook

1177-5475

Original Research
Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses
Yong-Hong Yi, Wen-Chao Guo, Wei-Wen Sun, Tao Su, Han Lin, et al
Biologics: Targets and Therapy 2008, 2:339-344
30 June 2008

Original Research
Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition
Bostjan Humar, Les McNoe, Anita Dunbier, Rosemary Heathcott, Antony W Braithwaite, Anthony E Reeve
Biologics: Targets and Therapy 2008, 2:329-337
30 June 2008

Original Research
Cognitive performance and the thymus among HIV-infected subjects receiving HAART
Maria J Miguez-Burbano, John E Lewis, Jose Moreno, Joel Fishman
Biologics: Targets and Therapy 2008, 2:321-327
30 June 2008


Review of the use of idursulfase in the treatment of mucopolysaccharidosis II
T Andrew Burrow, Nancy D Leslie
Biologics: Targets and Therapy 2008, 2:311-320
30 June 2008

Review
Mycophenolate mofetil in the treatment of lupus nephritis
Patrick FK Yong, David P D’Cruz
Biologics: Targets and Therapy 2008, 2:297-310
30 June 2008

Review
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Paul N Knoebl
Biologics: Targets and Therapy 2008, 2:285-296
30 June 2008

Review
Natalizumab in the treatment of Crohn’s disease
Danila Guagnozzi, Renzo Caprilli
Biologics: Targets and Therapy 2008, 2:275-284
30 June 2008

Review
Selenium and thyroid autoimmunity
Roberto Negro
Biologics: Targets and Therapy 2008, 2:265-273
30 June 2008

Original Research
Strategies for regenerating injured axons after spinal cord injury – insights from brain development
Masaki Ueno, Toshihide Yamashita
Biologics: Targets and Therapy 2008, 2:253-264
30 June 2008

Review
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
Matthew L Stoll, Alisa C Gotte
Biologics: Targets and Therapy 2008, 2:229-252
30 June 2008

Review
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
George P Kim, Axel Grothey
Biologics: Targets and Therapy 2008, 2:223-228
30 June 2008

Review
Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents
Antonio M Risitano, Bruno Rotoli
Biologics: Targets and Therapy 2008, 2:205-222
30 June 2008

Review
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
Jennifer S Carew, Steffan T Nawrocki, Francis J Giles, John L Cleveland
Biologics: Targets and Therapy 2008, 2:201-204
30 June 2008

Review
Natalizumab for the treatment of relapsing multiple sclerosis
Richard A Rudick, Michael A Panzara
Biologics: Targets and Therapy 2008, 2:189-199
30 June 2008

Review
The role of basiliximab in the evolving renal transplantation immunosuppression protocol
Paola Salis, Chiara Caccamo, Roberto Verzaro, Salvatore Gruttadauria, Mary Artero
Biologics: Targets and Therapy 2008, 2:175-188
30 June 2008

Review
Update on the use of etanercept across a spectrum of rheumatoid disorders
Bernard Combe
Biologics: Targets and Therapy 2008, 2:165-173
30 June 2008

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed